BioRestorative Therapies (BRTX)
NASDAQ:BRTX
Holding BRTX?
Track your performance easily

BioRestorative Therapies (BRTX) Income Statement

168 Followers

BioRestorative Therapies Income Statement

Last quarter (Q2 2024), BioRestorative Therapies's total revenue was $89.10K, an increase of 184.66% from the same quarter last year. In Q2, BioRestorative Therapies's net income was $-4.03M. See BioRestorative Therapies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 219.30K$ 145.80K$ 119.80K$ 46.00K$ 77.00K$ 130.00K
Cost of Revenue
$ 6.49K-----
Gross Profit
$ 212.81K$ 145.80K$ 119.80K$ 46.00K$ 77.00K$ 130.00K
Operating Expense
$ 13.01M$ 15.37M$ 19.09M$ 26.35M$ 2.83M$ 12.23M
Operating Income
$ -12.80M$ -15.22M$ -18.97M$ -26.31M$ -2.75M$ -12.10M
Net Non Operating Interest Income Expense
$ 496.40K$ 552.29K$ 372.17K$ -1.82M$ -1.64M$ -1.47M
Other Income Expense
$ 4.46M$ -86.33K$ -107.09K$ 16.18M$ 2.80M$ -1.92M
Pretax Income
$ -16.77M$ -14.58M$ -18.49M$ -44.30M$ -3.11M$ -10.86M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -16.60M$ -14.58M$ -18.49M$ -44.30M$ -11.27M$ -10.86M
Basic EPS
$ -2.24$ -3.42$ -5.11$ -37.30$ -40.00-
Diluted EPS
$ -2.24$ -3.42$ -5.11$ -37.30$ -40.00$ -0.66
Basic Average Shares
$ 23.25M$ 4.22M$ 3.62M$ 1.19M$ 394.70K$ 22.28M
Diluted Average Shares
$ 23.25M$ 4.22M$ 3.62M$ 1.19M$ 394.70K$ 22.28M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 13.02M$ 15.37M$ 19.09M$ 26.35M$ 2.83M$ 12.23M
Net Income From Continuing And Discontinued Operation
$ -14.86M$ -14.58M$ -18.50M$ -44.30M$ -11.27M$ -10.86M
Normalized Income
$ -10.33M-----
Interest Expense
------
EBIT
$ -15.39M$ -15.13M$ -18.51M$ -26.31M$ -9.63M$ -9.39M
EBITDA
$ -15.22M$ -14.97M$ -18.39M$ -26.22M$ -9.51M$ -5.50M
Currency in USD

BioRestorative Therapies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis